BCL2L1 and colorectal cancer: rhREG4 treatment also protected normal intestinal crypt cells from irradiation-induced apoptosis by enhancing the expression of Bcl-2, Bcl-xL, and survivin, in agreement with data from human colorectal cancer cells (Bishnupuri et al., 2010).